There aren’t many arguments remaining against the widescale proliferation of CBD products
The Validcare study, which has either already concluded in November or is due to conclude shortly, will provide a definitive verdict on how Pure CBD, Broad Spectrum CBD and Full Spectrum CBD impact the liver
At typical consumer level doses of 10-50 mg daily, the expectation is that there will be no significant perturbations in liver enzymes
However, the data is the data, so the verdict will be rendered once Validcare announces preliminary results
If the Validcare study plays out in the expected fashion, then it should put the liver safety question to bed for many
There will always be some who want more data and a longer study, but the really nice thing about the Validcare study is that a fair number of people enrolled in it have been taking CBD products for many months or years — so you are taking their word for it, as it’s just their attestation, but there should be some decent long term data in this study, too
One of the issues that I haven’t seen addressed is driving on CBD
We already have data that THC impairs driving, and that is one of the public safety concerns about Full Spectrum CBD
So I was happy to see a study on driving and CBD recently published in JAMA
Sleek
